Tenet Healthcare Projects Strong 2026 Performance on Margin Expansion, Cash Flow Strength, and Segment Growth
Margin Expansion and Disciplined Operations Drive Robust 2025 Results
Tenet Healthcare (NYSE: THC) posted notable improvements across most financial metrics in its fourth quarter and full-year 2025 results, driven by disciplined operations, efficient cost management, and continued demand for higher acuity services. Adjusted EBITDA in Q4 reached $1.18 billion, a 12.9% jump from the prior year, while the full-year figure landed at $4.57 billion, up 14.3%. Operating margins reflected this discipline, with Q4 2025 consolidated adjusted EBITDA margin rising to 21.4% versus 20.7% one year earlier.
| Metric | Q4 2025 | Q4 2024 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Net Operating Revenues ($M) | 5,527 | 5,073 | 21,310 | 20,675 |
| Net Income to Common ($M) | 371 | 318 | 1,407 | 3,200* |
| Adjusted EBITDA ($M) | 1,183 | 1,048 | 4,566 | 3,995 |
| Adjusted Diluted EPS | 4.70 | 3.44 | 16.78 | 11.88 |
| Free Cash Flow ($M) | 367 (Q4) | (661) (Q4) | 2,530 | 1,116 |
*2024 net income included a large one-time gain from hospital divestitures.
Cash Flow Generation and Lower Leverage Highlight Capital Strength
Tenet's operational performance translated into exceptional cash flow momentum. Free cash flow for 2025 climbed to $2.53 billion, more than doubling 2024's figure. Operating cash flow also improved sharply, while the company reduced its net debt to Adjusted EBITDA ratio to 2.25x, down from 2.54x a year earlier. Shareholder returns remain a focus, with $1.39 billion spent on repurchasing 8.8 million shares during 2025.
| Metric | 2025 | 2024 |
|---|---|---|
| Operating Cash Flow ($M) | 3,540 | 2,047 |
| Free Cash Flow ($M) | 2,530 | 1,116 |
| Net Debt/Adj. EBITDA | 2.25x | 2.54x |
| Shares Repurchased (M) | 8.8 | -- |
| Capital Expenditures ($M) | 1,010 | 931 |
Ambulatory and Hospital Segments Post Solid Growth; Acquisitions and Margins in Focus
The Ambulatory Care segment—anchored by United Surgical Partners International (USPI)—continued to deliver robust gains. Q4 revenues jumped nearly 14% year-over-year, driven by higher same-facility patient revenue, acquisitive expansion, and improved payer mix. Q4 Adjusted EBITDA for this segment grew 9.4% from the previous year, reaching $580 million, even as margins slipped modestly. On the Hospital side, Q4 operating revenues grew 7.3%, supported by higher acuity and favorable payer trends, which also drove margin improvement.
| Segment | Q4 2025 Revenues ($M) | YoY Change | Q4 2025 EBITDA Margin |
|---|---|---|---|
| Ambulatory | 1,433 | +13.8% | 40.5% |
| Hospital | 4,094 | +7.3% | 14.7% |
Outlook for 2026: Management Targets Further Margin Gains and Cash Generation
Looking ahead, Tenet projects continued momentum for 2026, with consolidated Adjusted EBITDA forecast to reach $4.49–$4.79 billion and free cash flow targeted between $2.94–$3.29 billion. Margins are expected to remain strong, while both the Ambulatory and Hospital segments are forecast to post healthy revenue and profitability growth. Notably, Tenet’s 2026 guidance excludes the benefit from the recently announced Conifer/CommonSpirit revenue cycle contract termination, which will provide substantial non-recurring revenue and capital infusions without distorting underlying operating trends.
| 2026 Guidance (low-high) | Consolidated | Ambulatory | Hospital |
|---|---|---|---|
| Net Op. Revenues ($B) | 21.5–22.3 | 5.5–5.7 | 16.0–16.6 |
| Adjusted EBITDA ($B) | 4.49–4.79 | 2.13–2.23 | 2.36–2.56 |
| Adj. EBITDA Margin | 20.9–21.5% | -- | -- |
| Free Cash Flow ($B) | 2.94–3.29 | -- | -- |
| Adj. EPS | 16.19–18.47 | -- | -- |
Strategic Capital Moves and Conifer Deal Enhance Flexibility
Recently, Tenet announced an agreement to receive $1.9 billion in annual payments from CommonSpirit Health via its Conifer Health Solutions arm, further enhancing financial flexibility and capital allocation—while maintaining support for CommonSpirit through the end of 2026 under favorable terms. This transaction is expected to produce a notable, though one-off, boost to cash flow and additional paid-in capital during 2026. Balance sheet strength is also supported by the completion of a $2.25 billion senior notes offering in late 2025, used to refinance maturing and higher-cost debt.
Key Takeaways: Underlying Growth, Margin Strength, Cash Generation Remain Intact
Tenet’s 2025 results and 2026 outlook reflect broad-based strength across multiple operating measures, underpinned by revenue quality, margin expansion, and disciplined capital allocation. Accelerating free cash generation, lower leverage, and a forward-looking management team position the company for continued operational and financial gains. Investors and market watchers will be tuned in to management's webcast and slides for additional context on execution and mid-term strategic priorities.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI